ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 663285 6-N-(Aminoethyl-2-(4-morpholino))-6-chloro-5,8-quinolinedione 0.0123744972338278 0.043493978
NSC 667722 Null 0.0123744972338278 -0.077125194
NSC 703823 3-Hydroxy-16(4'-pyridylmethylene)-17-oxo-1,3,5(10)-estratriene 0.0123744972338278 0.20271701
NSC 717838 Null 0.0123744972338278 -0.01771787
NSC 742838 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamide, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl-, hydrochloride 0.0123744972338278 -0.048020822
NSC 117187 Indole-2,3-dione, 5,7-dichloro-, 3-[(o-nitrophenyl) hydrazone] 0.0123744972338279 0.13254836
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.0123744972338279 0.25941451
NSC 46691 Null 0.0123744972338279 -0.0083214079
NSC 629971 Camptothecin Derivative 0.0133299224082802 0.91055069
NSC 642009 Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester 0.0133299224082802 0.26789643
Total:64  Current:20    [First] [Prev] [Next] [Last]